Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)

New Relic Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	30,654	13,212	13,884	7,833	11,431	15,190
Market Cap Growth	22.21%	-4.84%	77.24%	-31.47%	-24.75%	-
Enterprise Value	28,944	11,916	12,009	5,381	8,997	12,310
Last Close Price	49.70	21.39	22.38	12.63	18.44	24.51
PE Ratio	42.84	18.75	47.13	158.90	632.98	-
Forward PE	100.07	36.46	104.70	145.14	85.29	-
PS Ratio	24.77	11.07	13.69	9.49	12.31	23.19
PB Ratio	5.44	2.39	2.85	1.70	2.52	3.36
P/TBV Ratio	5.62	2.47	2.98	1.78	2.63	3.55
P/FCF Ratio	2022.89	37289.17	76.87	640.46	-	-
P/OCF Ratio	109.82	46.99	33.35	33.55	-	-
EV/Sales Ratio	23.38	9.98	11.84	6.52	9.69	18.79
EV/EBITDA Ratio	39.20	35.67	41.80	63.38	337.42	-
EV/EBIT Ratio	48.00	57.68	62.80	-	-	-
EV/FCF Ratio	1910.05	33631.43	66.49	439.99	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.03	-	-
Debt / EBITDA Ratio	0.14	0.15	0.17	1.77	-	-
Debt / FCF Ratio	3.30	141.19	0.28	12.27	-	-
Asset Turnover	0.22	0.21	0.20	0.17	0.19	0.16
Inventory Turnover	1.39	1.44	1.06	0.94	0.97	0.52
Quick Ratio	6.39	7.51	6.54	7.27	12.18	10.22
Current Ratio	10.22	8.39	7.30	7.96	13.33	11.14
Return on Equity (ROE)	13.25%	13.28%	5.98%	0.99%	-0.04%	-6.35%
Return on Assets (ROA)	2.30%	2.29%	2.30%	-0.47%	-1.38%	-3.88%
Return on Capital (ROIC)	2.46%	2.46%	2.47%	-0.51%	-1.50%	-4.33%
Return on Capital Employed (ROCE)	3.70%	3.70%	3.80%	-	-	-
Earnings Yield	2.34%	5.33%	2.12%	0.63%	0.16%	-1.43%
FCF Yield	0.05%	0.00%	1.30%	0.16%	-4.44%	-1.76%
Dividend Yield	0.24%	0.57%	0.22%	-	-	-
Payout Ratio	7.31%	7.43%	0.50%	2.48%	-	-
Buyback Yield / Dilution	-3.26%	-0.70%	0.40%	-2.37%	-2.42%	-10.22%
Total Shareholder Return	-3.03%	-0.12%	0.62%	-2.37%	-2.42%	-10.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.